IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 55 filers reported holding IRADIMED CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $558,618 | -9.9% | 12,590 | -3.1% | 0.00% | – |
| Q2 2023 | $620,143 | +18.5% | 12,990 | -2.3% | 0.00% | – |
| Q1 2023 | $523,355 | +39.1% | 13,300 | 0.0% | 0.00% | – |
| Q4 2022 | $376,257 | -1.5% | 13,300 | +4.7% | 0.00% | – |
| Q3 2022 | $382,000 | -11.4% | 12,700 | 0.0% | 0.00% | – |
| Q2 2022 | $431,000 | -21.9% | 12,700 | +3.3% | 0.00% | – |
| Q1 2022 | $552,000 | -2.8% | 12,300 | 0.0% | 0.00% | – |
| Q4 2021 | $568,000 | +37.5% | 12,300 | 0.0% | 0.00% | – |
| Q3 2021 | $413,000 | +14.1% | 12,300 | 0.0% | 0.00% | – |
| Q2 2021 | $362,000 | +16.0% | 12,300 | +1.7% | 0.00% | – |
| Q1 2021 | $312,000 | +13.0% | 12,100 | 0.0% | 0.00% | – |
| Q4 2020 | $276,000 | +6.6% | 12,100 | 0.0% | 0.00% | – |
| Q3 2020 | $259,000 | -17.3% | 12,100 | -10.4% | 0.00% | – |
| Q2 2020 | $313,000 | +48.3% | 13,500 | +36.4% | 0.00% | – |
| Q1 2020 | $211,000 | – | 9,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |